More Starpharma Holdings Limited news
Starpharma Holdings LimitedASX: SPL

S&P DJI Announces September 2022 Quarterly Rebalance

Sep 2, 2022 at 7:22 AM EDT · Issued by Starpharma Holdings Limited

Filed with ASX · Sep 2, 2022 at 7:22 AM EDT · 4 pages · English

On 6ix: 6ix.com/news/sandp-dji-announces-september-2022-quarterly-rebalance-24

Starpharma Holdings Limited on 6ix

Earlier from Starpharma

  • Starpharma annual report and full year financial resultsAug 25, 2022
  • Starpharma signs new DEP agreement with MSDAug 10, 2022
  • Quarterly Activities Report & Appendix 4CJul 28, 2022
  • VIRALEZE Protects Against Omicron in Viral Challenge ModelJul 20, 2022
  • VIRALEZE relaunched by LloydsPharmacy in the UKJun 30, 2022

Later from Starpharma

  • New clinical data for DEP cabazitaxel in prostate cancerSep 11, 2022
  • VIRALEZE distribution agreement for Hong Kong and MacauOct 20, 2022
  • AGM Chairman address and CEO presentationNov 29, 2022
  • Positive AZD0466 clinical data presented by AstraZenecaDec 13, 2022
  • VIRALEZE Nasal Spray Registered in IndonesiaDec 14, 2022
All Starpharma news releases↗

Follow Starpharma into a list and get an email when it puts out news.

Follow Starpharma
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer